GlassScriptPhysician profile
Babette Glister
NPI 1710938337
$1,462.93
in general payments reported to CMS, 2019-2025
18 companies · $535 in 2025
The $535 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.16 · 2020: $136 · 2021: $44.26 · 2022: $104 · 2023: $136 · 2024: $474 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,145.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $323.16 | 2020-2025 | Mounjaro, Zepbound, Trulicity |
| Novo Nordisk INC | $284.58 | 2022-2025 | Ozempic, Rybelsus |
| Dexcom, INC. | $183.11 | 2020-2025 | Dexcom G6 Transmitter |
| Cequr Corporation | $105.24 | 2023-2025 | Cequr Simplicity |
| Amneal Pharmaceuticals LLC | $79.97 | 2024-2025 | Unithroid |
| Abbvie INC. | $75.27 | 2020-2025 | |
| Medtronic, INC. | $75.20 | 2021-2025 | Minimed 780g |
| Xeris Pharmaceuticals, INC. | $61.86 | 2022-2025 | Recorlev |
| Beta Bionics, INC. | $56.25 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Radius Health, INC. | $48.26 | 2024-2025 | Tymlos |
| Sanofi-Aventis U.S. LLC | $42.41 | 2022-2024 | |
| Alexion Pharmaceuticals, INC. | $25.03 | 2025 | Strensiq |
| Amgen INC. | $23.59 | 2024 | Prolia, Evenity |
| Almatica Pharma LLC | $18.14 | 2025 | Teriparatide |
| Endo Pharmaceuticals INC. | $16.75 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $16.41 | 2019 | |
| Nevro Corp. | $14.57 | 2023 | Senza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Babette Glister listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.